Naturalendo Tech (A168330) Stock Overview
Engages in the research, development, manufacture, and sale of physical chemistry and biology, biological agents, food additives, and health functional food in South Korea. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
A168330 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Naturalendo Tech Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩3,210.00 |
| 52 Week High | ₩6,300.00 |
| 52 Week Low | ₩1,278.00 |
| Beta | 0.033 |
| 1 Month Change | 42.04% |
| 3 Month Change | 9.18% |
| 1 Year Change | 125.42% |
| 3 Year Change | -0.62% |
| 5 Year Change | n/a |
| Change since IPO | -86.36% |
Recent News & Updates
There's No Escaping Naturalendo Tech Co., Ltd.'s (KOSDAQ:168330) Muted Revenues Despite A 36% Share Price Rise
Dec 05
Would Naturalendo Tech (KOSDAQ:168330) Be Better Off With Less Debt?
Nov 20Naturalendo Tech Co., Ltd.'s (KOSDAQ:168330) 32% Dip In Price Shows Sentiment Is Matching Revenues
Jul 11Recent updates
There's No Escaping Naturalendo Tech Co., Ltd.'s (KOSDAQ:168330) Muted Revenues Despite A 36% Share Price Rise
Dec 05Would Naturalendo Tech (KOSDAQ:168330) Be Better Off With Less Debt?
Nov 20Naturalendo Tech Co., Ltd.'s (KOSDAQ:168330) 32% Dip In Price Shows Sentiment Is Matching Revenues
Jul 11Naturalendo Tech Co., Ltd. (KOSDAQ:168330) Stock Catapults 29% Though Its Price And Business Still Lag The Industry
May 20Naturalendo Tech Co., Ltd.'s (KOSDAQ:168330) Price Is Right But Growth Is Lacking
Apr 03Naturalendo Tech Co., Ltd. (KOSDAQ:168330) Looks Inexpensive But Perhaps Not Attractive Enough
Nov 13Is Naturalendo Tech (KOSDAQ:168330) A Risky Investment?
Mar 26Shareholder Returns
| A168330 | KR Biotechs | KR Market | |
|---|---|---|---|
| 7D | 39.6% | -2.1% | 5.3% |
| 1Y | 125.4% | 56.2% | 73.0% |
Return vs Industry: A168330 exceeded the KR Biotechs industry which returned 50% over the past year.
Return vs Market: A168330 exceeded the KR Market which returned 65.7% over the past year.
Price Volatility
| A168330 volatility | |
|---|---|
| A168330 Average Weekly Movement | 11.2% |
| Biotechs Industry Average Movement | 8.1% |
| Market Average Movement | 5.4% |
| 10% most volatile stocks in KR Market | 11.5% |
| 10% least volatile stocks in KR Market | 2.6% |
Stable Share Price: A168330's share price has been volatile over the past 3 months compared to the KR market.
Volatility Over Time: A168330's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 74 | Hee-do Kim | www.naturalendo.co.kr |
Naturalendo Tech Co., Ltd. engages in the research, development, manufacture, and sale of physical chemistry and biology, biological agents, food additives, and health functional food in South Korea. The company offers EstroG-100, a functional raw material for women's menopause; Seoul National University wonder, a diet ingredient; YGF 251, a phyto height growth booster; NET 2401, a multiway sleep-wake cycle regulator; Stauntonia hexaphylla Fruit Extract, an anti-inflammatory superfood; Q.186 complex for improving male menopause; NET 1701, a men’s prostate and urinary support; and Quercus acuta Thunb. fruit extract for preventing skin aging caused by ultraviolet rays.
Naturalendo Tech Co., Ltd. Fundamentals Summary
| A168330 fundamental statistics | |
|---|---|
| Market cap | ₩101.35b |
| Earnings (TTM) | -₩3.29b |
| Revenue (TTM) | ₩21.87b |
Is A168330 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A168330 income statement (TTM) | |
|---|---|
| Revenue | ₩21.87b |
| Cost of Revenue | ₩12.50b |
| Gross Profit | ₩9.37b |
| Other Expenses | ₩12.66b |
| Earnings | -₩3.29b |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -104.14 |
| Gross Margin | 42.85% |
| Net Profit Margin | -15.03% |
| Debt/Equity Ratio | 35.7% |
How did A168330 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/12/08 03:21 |
| End of Day Share Price | 2025/12/08 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Naturalendo Tech Co., Ltd. is covered by 7 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Hyuk Jin Yoon | Eugene Investment & Securities Co Ltd. |
| Dong Ha Kim | Kyobo Securities Co., Ltd |
| Gi Kim | LS Securities Co., Ltd. |